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Our aim was to investigate whether birth weight in mothers with diabetes mellitus type 1 is higher as compared to nondiabetic
controls. Methods. A retrospective study was performed using an existing database covering the region of Flanders, Belgium. Data
includedthepresenceofdiabetes type 1,hypertension,parity,maternalage,theuseartiﬁcialreproductive technology,fetal-neona-
tal death, congenital anomalies,admissionto a neonatalintensive care unit, and delivery by Caesarean section or vaginally. Results.
In the period studied, 354 women with diabetes type 1 gave birth and were compared with 177.471 controls. Women with type 1
diabetes more often had a maternal age of over 35 years (16.7% versus 12.0%, P = .008, OR 1.46; 95% CI 1.09–1.95). They more
frequently suﬀered hypertension in pregnancy (19.5% versus 4.7%, P<. 0001, OR 4.91; 95% CI 3.73–6.44). Perinatal death was
signiﬁcantlyhigherin thediabetes mellitus group (3.05%versus 0.73%,P<. 0001,OR4.28;95% CI 2.22–8.01).Caesarean section
was performed almost 5 times as frequently in the diabetes versus the control group (OR 4.57; 95% CI 3.70–5.65). Birth weight
was signiﬁcantly higher in diabetic pregnant women from 33 until 38 weeks included, but those reaching 39 weeks and later were
notdiﬀerent withcontrolgroups. Conclusion.In Belgium,diabetic pregnancy still carries a highriskforfetal andmaternalcompli-
cations;in general birth weight is signiﬁcantly higher but for those reaching term there is no signiﬁcantdiﬀerence in birth weight.
1.Introduction
The incidence of type 1 diabetes mellitus in Belgium
varies between 10.9 to 15.4/100.000 [1]. In type 1 diabetic
pregnancies, an increase in congenital malformations, mis-
carriage, macrosomia, shoulder dystocia, and other obstetric
complications is described [2–19]. Macrosomia is deﬁned as
birth weight above the 90th percentile for gestational age.
According to the modiﬁed Pederson hypothesis, maternal
hyperglycemia results in transplacental diﬀusion of a higher
amount of glucose to the fetus, resulting in a stimulation of
the fetal beta cells and increased fetal insulin secretion. This
ﬁnally results in fetal macrosomia. Macrosomia is related
to obstetrical and neonatal complications such as asphyxia,
shoulder dystocia, and neonatal trauma during delivery
[6–9].
The aim of this study was to look for diﬀerences in birth
weight in patients with diabetes type 1 as compared to the
general obstetric population in the context of the actual
therapy of diabetes.
2.Methods
A retrospective analysis was performed of an existing data
base. The Study Centre for Perinatal Epidemiology registers
data on all hospital deliveries (this is 99% of all deliveries)
and most home deliveries in Flanders, Belgium. Data are
collected on both maternal and neonatal outcome. The
diagnosis of type 1 diabetes was accepted as given by the
treating physician. For this study, hypertension was deﬁned
as a systolic blood pressure ≥140mmHg and/or diastolic
≥90mmHg; no further subdivision in pre-eclampsia, ges-
tational hypertension, and pre-existent hypertension was
made. Fetal death is death before delivery, early neonatal
death is death in the ﬁrst 28 days of live, and perinatal death
was considered the sum of fetal and early neonatal death.
For every fetus, the presence of congenital anomalies was
registered as eventual transfer to a neonatal intensive care
unit. Caesarean or vaginal delivery and the use of forceps or
vacuum are also registered. Women with type 2 diabetes or
gestational diabetes were excluded from our study.2 Obstetrics and Gynecology International
Table 1: Maternal data.
Type 1 % Control % P value Odds ratio 95% Cl
N 354 177471
Maternal age ≥ 35 years 59 16.7 21362 12.0 .008 1.46 [1.09–1.95]
Parity = 1 179 50.6 83711 47.1 .201 1.15 [0.93–1.42]
Parity > 1 175 49.4 93760 52.8 .201 0.87 [0.70–1.08]
Hypertension 69 19.5 8346 4.7 .000 4.91 [3.73–6.44]
IVF 7 2.0 3779 2.1 .843 0.93 [0.40–2.02]
Hormonal stimulation 11 3.1 3489 2.0 .122 1.60 [0.83–2.99]
IVF: in vitro fertlisation.CI: Conﬁdence interval.
Table 2: Fetal-neonatal outcome.
type 1 % Control % P value Odds ratio 95% CI
N 361 180842
Fetal death 9 2.49 923 0.51 .000 4.98 [2.40–9.96]
Perinatal death 11 3.05 1319 0.73 .000 4.28 [2.22–8.01]
Early neonatal death 2 0.57 396 0.22 .165 2.59 —
Late neonatal death 2 0.57 396 0.22 .174 2.54 —
Congenital abnormalities 21 5.80 3017 1.70 .000 3.64 [2.28–5.76]
NICU 80 22.20 7616 4.20 .000 6.48 [5.01–8.37]
Cesarean section 184 51.00 33490 18.50 .000 4.57 [3.70–5.65]
Forceps + ventouse 42 11.60 19738 10.90 .661 1.07 [0.77–1.50]
<37w 98 27.7 13069 7.4 .000 4.82 [3.79–6.12]
<34w 26 7.3 3350 1.9 .000 4.12 [2.70–6.24]
<28w 5 1.4 765 0.4 .000 3.31 [1.21–8.30]
NICU: neonatal intensive care unit. CI: Conﬁdence interval.
Dichotomic variables were compared using Chi squared
test, signiﬁcance accepted at P<. 05, odds ratios, and
95% conﬁdence intervals. To compare birthweight as a
continuous variable per gestational week, a Shapiro-Wilk
test was performed to test for normality; nonnormally
distributed data were compared using the Mann-Whitney
test, signiﬁcance accepted at P<. 05. Statistical analysis was
done with SPSS 16.0.
3.Results
We studied patients who gave birth between January, 1st,
2002and December, 1st 2004; during this period 354 women
with type 1 diabetes gave birth and 177.407 control women.
Table 1 gives a general overview of the obstetric data of
our population. There were signiﬁcantly more women in the
type 1 diabetes group over age 35 years and signiﬁcantly
more maternal hypertension. Table 2 demonstrates the fetal-
neonatal outcome. Clearly fetal and perinatal deaths are
signiﬁcantly higher in the type 1 diabetes group as compared
tocontrols,andsigniﬁcantlymorecongenitalanomalieswere
seen in neonates from diabetic mothers. This correlates with
more transfers to a neonatal intensive care unit. Neonates
were almost 5 times as often born by Caesarean section in
case of maternal diabetes type 1. Babies of mothers with
diabetes type 1 were also more often preterm.
Table 3 presents birth weight per gestational week for
diabetes type 1 and the control group. Figure 1 presents a
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Figure 1: Median birthweight versus gestational age.
graphic view ofthe median birth weight pergestational week
in diabetic and nondiabetic pregnancies.
For none of the gestational weeks birthweight was
normally distributed (probably due to low numbers), as
the number of deliveries in the type 1 diabetic group was
extremely low before 33 weeks (less than 5), we only com-
pared median birthweight from week 33 till week 41. ThisObstetrics and Gynecology International 3
Table 3: Birth weight per gestational week.
Gestational week Diabetes type 1 Control P (Mann-Whitney
Deliveries (=N) Median birthweight (g) Deliveries (=N) Median birthweight (g)
24 1 780 143 770 —
25 1 650 184 820 —
26 2 1075 231 900 —
27 1 723 270 1079 —
28 3 1352 263 1280 —
29 5 1070 376 1410 —
30 2 1350 467 1618 —
31 3 1600 730 1880 —
32 3 2000 1036 1992 —
33 8 2745 1843 2240 <.001
34 8 2448 2999 2460 <.001
35 20 3200 6218 2710 <.001
36 48 3505 13391 2980 <.001
37 91 3680 32196 3200 <.001
38 113 3650 47517 3360 <.001
39 35 3575 54628 3500 .076
40 12 3525 16955 3610 .856
41 5 3450 1022 3679 .627
demonstrates, as shown in Table 3, that until 38 weeks there
isasigniﬁcantdiﬀerenceinbirthweightforthediabeticpreg-
nancies;from39weeksonnosigniﬁcant diﬀerenceispresent.
4.Discussion
Althougha higher birth weight in type 1 diabetes is generally
accepted, only few studies have actually described birth
weight per gestational week in diabetic pregnancies as
compared to nondiabetic controls. Most studies give mean
birth weights, not specifying gestational age. Lauszus et al.
[13] described birth weight but made a division only in term
and preterm pregnancies not allowing to determine whether
ad i ﬀerence is or is not present at diﬀerent gestational ages.
Sibai et al. [14] compared birthweight in pregestational
diabetes,chronichypertension,anduncomplicatedpregnan-
cies before 35 weeks and between 35 and 37 weeks and noted
a higher birthweight in pregestational diabetes. Dos Santos
Silvaetal.[19]madeaveryrawdivisioninlessthan33weeks,
between33and36weeksandmorethan36weeksbutdidnot
use a control group.
The only study comparable to our present one we were
abletoﬁndwasthatbyJensenetal.[10]whocomparedmean
birth weight in the diabetic group versus a control group
and did not ﬁnd a signiﬁcant diﬀerence. Evers et al. [16, 17]
also used a control group but did not provide data per
gestationalweek.Asfarasweknowthisistheﬁrstnationwide
study presenting data on birth weight per gestational week in
pregnancies withtype1diabetesversusnondiabeticcontrols.
Our data conﬁrm that neonates from mothers with type
1 diabetes have a signiﬁcantly increased risk for perinatal
death, are more frequently born by Caesarean section,
have more congenital anomalies, and more frequently need
neonatal intensive care. As the number of babies born from
type 1 diabetic mothers below 33 weeks was extremely low,
it seemed not relevant to make a statistical comparison.
When analyzing data between 33 and 41 weeks a signiﬁcant
diﬀerence was seen until 38 weeks. From 39 weeks on, there
was no signiﬁcant diﬀerence in birth weight between both
groups. This can be due to chance, but another explanation
might be that those pregnancies with type 1 diabetes that
continue until 39 and more weeks are the ones with the
least problems; all others will have been induced in the mean
time.
Our study has several important limitations. We do not
have any data on the quality of the diabetic control of our
patients, we cannot also control for maternal weight or
m a t e r n a lw e i g h tg a i n ,n o rc a nw ee x c l u d et h ei n ﬂ u e n c eo f
other risk factors such as maternal smoking.
5.Conclusion
This retrospective analysis demonstrates that birth weight
for neonates from mothers with type 1 diabetes is higher
than that in a control group but the diﬀerence disappears at
39 weeks, probably because only the best regulated diabetic
mothers continued their pregnancy until that week.
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